The pharmaceutical industry must continue to push forwards in 2023 through a complex web of challenges. Having innovated its way through the pandemic, the industry continues to see a rise in global demand, forcing companies to rethink their long-term strategies for sustainability. The product landscape also continues to rapidly evolve, which is likely to exacerbate fragmentation to the sector.
Further, pharmaceutical organisations are not immume from the more generic market challenges such as:
- Supply chain pressures
- Tighter and increasing regulatory reviews and standards
- Talent shortages
These factors are causing pharmaceutical companies to change their strategies, however, they must do so in a way that combines tactical short-term actions with long-term initiatives that tie to a larger, strategic vision.
We are experts in creating agents of change, cultures of innovation and leaders who thrive when confronted with ambiguity. We have created unique development solutions to suit the needs of our pharmaceutical client portfolio, including Polpharma and Stryker.